Fermenta Biotec.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE225B01021
  • NSEID: FERMENTA
  • BSEID: 506414
INR
305.80
3.15 (1.04%)
BSENSE

May 25

BSE+NSE Vol: 17.18 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 261671,
    "name": "Fermenta Biotec.",
    "stock_name": "Fermenta Biotec.",
    "full_name": "Fermenta Biotech Ltd",
    "name_url": "stocks-analysis/fermenta-biotec",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "305.80",
    "chg": 3.15,
    "chgp": "1.04%",
    "dir": 1,
    "prev_price": "302.65",
    "mcapval": "901.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506414,
    "symbol": "FERMENTA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE225B01021",
    "curr_date": "May 25",
    "curr_time": "",
    "bse_nse_vol": "17.18 k",
    "exc_status": "Active",
    "traded_date": "May 25, 2026",
    "traded_date_str": "2026 05 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fermenta-biotec-261671-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Fermenta Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fermenta-biotech-ltd-is-rated-strong-sell-4007892",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FermentaBiotech_mojoScore_4007892.png",
        "date": "2026-05-23 10:10:18",
        "description": "Fermenta Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Apr 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 23 May 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "When is the next results date for Fermenta Biotech Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-fermenta-biotech-ltd-4001689",
        "imagepath": "",
        "date": "2026-05-20 23:18:22",
        "description": "The next results date for Fermenta Biotech Ltd is scheduled for 26 May 2026...."
      },
      {
        "title": "Fermenta Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fermenta-biotech-ltd-is-rated-strong-sell-3987384",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FermentaBiotech_mojoScore_3987384.png",
        "date": "2026-05-12 10:10:25",
        "description": "Fermenta Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Fermenta Biotech Ltd Locks at Lower Circuit With 20% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3974155",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FermentaBiotech_stocks_hitting_lower_circuit_3974155.png",
        "date": "2026-05-04 14:00:06",
        "description": "At Rs 248.85, sellers were still queuing — but there were no buyers willing to take the other side. Fermenta Biotech Ltd locked at its lower circuit of 20% on 4 May 2026, with unfilled sell orders and a frozen price that capped losses for the day."
      },
      {
        "title": "Fermenta Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fermenta-biotech-ltd-is-rated-strong-sell-3972137",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FermentaBiotech_mojoScore_3972137.png",
        "date": "2026-05-01 10:10:17",
        "description": "Fermenta Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Apr 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 01 May 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Fermenta Biotech Downgraded to Strong Sell Amid Mixed Valuation and Weak Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fermenta-biotech-downgraded-to-strong-sell-amid-mixed-valuation-and-weak-financial-trends-3953350",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/FermentaBiotech_mojoScore_3953350.png",
        "date": "2026-04-20 08:11:13",
        "description": "Fermenta Biotech Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 17 April 2026, driven by a complex interplay of valuation improvements, deteriorating financial trends, weak quality metrics, and unfavourable technical signals. Despite a very attractive valuation profile, the company’s long-term fundamentals and recent quarterly performance have raised significant concerns among analysts, prompting a reassessment of its investment appeal."
      },
      {
        "title": "Fermenta Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fermenta-biotech-ltd-is-rated-sell-3950816",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/FermentaBiotech_mojoScore_3950816.png",
        "date": "2026-04-17 10:10:03",
        "description": "Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Fermenta Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-ltd-valuation-shifts-signal-renewed-price-attractiveness-3946399",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/FermentaBiotech_valuationdot_3946399.png",
        "date": "2026-04-15 08:00:33",
        "description": "Fermenta Biotech Ltd has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite recent market headwinds and a downgrade in its overall mojo grade to Sell. This change reflects a notable improvement in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the micro-cap pharmaceutical and biotechnology firm as a compelling value proposition relative to its peers and historical benchmarks."
      },
      {
        "title": "Fermenta Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fermenta-biotech-ltd-is-rated-sell-3934286",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/FermentaBiotech_mojoScore_3934286.png",
        "date": "2026-04-06 10:10:03",
        "description": "Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 550,
    "sid": "261671",
    "stock_news_url": "https://www.marketsmojo.com/news/fermenta-biotech-261671"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 And Consideration Of Final Equity Dividend If Any.",
      "datetime": "19-May-2026",
      "details": "Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve audited financial results (standalone and consolidated) of the Company for the quarter and financial year ended March 31 2026 and consideration of final equity dividend if any.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-May-2026",
      "details": "Publication of IEPF related notice for equity shareholders",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "28-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Fermenta Biotech Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L99999MH1951PLC008485</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>17.39</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>CAREBBBSTABLE</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CARE RATINGS LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: VARADVINAYAK KHAMBETE <br/> Designation: COMPANY SECRETARY AND HEAD LEGAL <br/> EmailId: varadvinayak.khambete@fermentabiotech.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: SUMESH GANDHI <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: sumesh.gandhi@fermentabiotech.com</div> </div> <div> <br/> Date: 28/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "26 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has declared <strong>50%</strong> dividend, ex-date: 06 Aug 25",
          "dt": "2025-08-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has announced <strong>5:5</strong> stock split, ex-date: 08 Aug 18",
          "dt": "2018-08-08",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 13 Feb 20",
          "dt": "2020-02-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 And Consideration Of Final Equity Dividend If Any.

19-May-2026 | Source : BSE

Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve audited financial results (standalone and consolidated) of the Company for the quarter and financial year ended March 31 2026 and consideration of final equity dividend if any.

Announcement under Regulation 30 (LODR)-Newspaper Publication

07-May-2026 | Source : BSE

Publication of IEPF related notice for equity shareholders

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

28-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyFermenta Biotech Ltd
2CIN NO.L99999MH1951PLC008485
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 17.39
4Highest Credit Rating during the previous FY CAREBBBSTABLE
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: VARADVINAYAK KHAMBETE
Designation: COMPANY SECRETARY AND HEAD LEGAL
EmailId: varadvinayak.khambete@fermentabiotech.com
Name of the Chief Financial Officer: SUMESH GANDHI
Designation: CHIEF FINANCIAL OFFICER
EmailId: sumesh.gandhi@fermentabiotech.com

Date: 28/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

26 May 2026

stock-summary
DIVIDEND

Fermenta Biotech Ltd has declared 50% dividend, ex-date: 06 Aug 25

stock-summary
SPLITS

Fermenta Biotech Ltd has announced 5:5 stock split, ex-date: 08 Aug 18

stock-summary
BONUS

Fermenta Biotech Ltd has announced 2:1 bonus issue, ex-date: 13 Feb 20

stock-summary
RIGHTS

No Rights history available